- About
About
- Patients
The Conference “Leukemia and Lymphomas. Therapy and Basic Research,” held twice a year, is a platform for sharing experiences, broadcasting new ideas and networking in the field of hematology.
13 years ago, during her second pregnancy, Julia Gubaidullina found out that she had aggressive lymphoma. This story is about how difficult it was to defend her right to motherhood, about resisting public opinion and stereotypes, about the support of loved ones, about faith in the best and in the professionalism of doctors. The participant of the project “I Will Live!” tells us about all of this in an exclusive interview.
The annual Scientific and Practical Conference "Polysystem Orphan Diseases in Adults as an Interdisciplinary Problem" (ПОМП-2024) was held in Moscow.
Alexey Motyakov, 34, from Murom, came to the NMRC for Hematology of the Ministry of Health of Russia to help save the life of a seriously ill person.
On the first day of the Conference, a meeting of the chief freelance hematologists of the Southern and North Caucasus Federal Districts will be held.
Gennady Miller is a hero of the project "I Will Live!" Family, work, his wife's pregnancy – and a serious illness. And yet, he did it. What helped him return to normal life? How do you deal with the risk of relapse?
Seven years ago, Lilia underwent a bone marrow transplant. She went through this tribulation with her family and came to the filming of the project "I Will Live!" with her husband, son and one-year-old daughter.
On 26 April 1986, the largest accident at a nuclear facility in history occurred at the Chernobyl Nuclear Power Plant. The accident became a challenge for everyone – the leadership of the USSR, rescuers, the military and, of course, for doctors. A group of scientists and doctors led by A.I. Vorobyov found a way to determine the radiation dose without using dosimeters.
From 11-13 April 2024, the event was attended by more than four thousand specialists, two thousand of whom joined online.
Alexey has donated blood more than 150 times. He decided to become a donor in 2010 after the explosions in the metro at the Lubyanka and Park Kultury stations. On 22 March, Alexey attended a concert at Crocus City Hall, and on the 23rd he came to a donate at the NMRC for Hematology.
21.03.2024Relaunch of the Project "I Will Live"-2024"I Will Live!" is a large–scale social project of the NMRC for Hematology of the Ministry of Health of Russia, designed to help those who are currently fighting cancer.
The Clinical and Diagnostic Department of Hematology and Hemostasis Disorders of the NMRC for Hematology of the Ministry of Health of the Russian Federation is conducting a clinical trial of the ANB-002-1/ SAFRAN gene therapy drug in patients with severe hemophilia B. The drug was developed by the Russian biotechnology company BIOCAD.
- Patients
